National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 19545-19546 [07-1894]

Download as PDF Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Respiratory Distress in Newborns and Its Relationship to B Streptococcal Colonization. Date: May 10, 2007. Time: 12 p.m. to 1:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6100 Executive Boulevard, 5B01, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Hameed Khan, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 435–6902, khanh@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS). BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES pwalker on PROD1PC71 with NOTICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice 17:04 Apr 17, 2007 Jkt 211001 Name of Committee: National Institute on Aging Special Emphasis Panel, Longitudinal Study Contract. Date: April 25, 2007. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Wilbur C. Hadden, PhD, Health Science Administrator, National Institute on Aging, Gateway Building, Room 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, haddenw@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS). Dated: April 11, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1892 Filed 4–17–07; 8:45 am] would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Design, Synthesis and Preclinical Testing of Potential Treatment Agents for Drug Addiction. Date: May 8, 2007. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Jury’s Washington Hotel, 1500 New Hampshire Avenue, Washington, DC 20036. Contact Person: Mark Swieter, PhD, Chief, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite 220, Bethesda, MD 20892–8401, (301) 435–1389, ms80x@nih.gov. Name of Committee: National Institute on Drug Abuse Initial Review Group Health Services Research Subcommittee. Date: June 5–6, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: Meenaxi Hiremath, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6101 Executive Blvd., Suite 220, MSC 8401, Bethesda, MD 20892, 301–402–7964, mh392g@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS). Dated: April 10, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1893 Filed 4–17–07; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Dated: April 11, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1891 Filed 4–17–07; 8:45 am] VerDate Aug<31>2005 is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 19545 National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\18APN1.SGM 18APN1 19546 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices pwalker on PROD1PC71 with NOTICES provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Diabetes, Endocrinology and Metabolic Diseases B Subcommittee. Date: May 30–31, 2007. Open: May 30, 2007, 3:30 p.m. to 4 p.m. Agenda: To review procedures and discuss policy. Place: Intercontinental Toronto Centre, 225 Front Street West, Toronto, ON. Closed: May 30, 2007, 4 p.m. to 7:30 p.m. Agenda: To review and evaluate grant applications. Place: Intercontinental Toronto Centre, 225 Front Street West, Toronto, ON. Closed: May 31, 2007, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Intercontinental Toronto Centre, 225 Front Street West, Toronto, ON. Contact Person: John F. Connaughton, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 916, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7797. connaughtonj@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Kidney, Urologic and Hematologic Diseases D Subcommittee. Date: June 27–28, 2007. Open: June 27, 2007, 2 p.m. to 2:30 p.m. Agenda: To review procedures and discuss policy. Place: Crystal City Courtyard by Marriott, 2899 Jefferson Davis Hwy, Arlington, VA 22202. Closed: June 27, 2007, 2:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Courtyard by Marriott, 2899 Jefferson Davis Hwy, Arlington, VA 22202. Closed: June 28, 2007, 8 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Courtyard by Marriott, 2899 Jefferson Davis Hwy, Arlington, VA 22202. Contact Person: Neal A. Musto, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 751, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7798, muston@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) VerDate Aug<31>2005 17:04 Apr 17, 2007 Jkt 211001 Dated: April 11, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1894 Filed 4–17–07; 8:45am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Commission on Digestive Diseases, June 18, 2007, 9 a.m. to June 19, 2007, 12 p.m., Sheraton Crystal City, 1800 Jefferson Davis Highway (Rt. 1), Grand Ballroom C, Arlington, VA 22202 which was published in the Federal Register on March 28, 2007, 72 FR 14597. To elaborate on times and dates of the meeting: June 18, 2007 from 9 a.m. until 5 p.m. and on June 19, 2007 from 9 a.m. until 12 noon. The meeting is open to the public. Dated: April 11, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1898 Filed 4–17–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Mechanisms of Viral Innate Immunity. PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 Date: May 11, 2007. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 4206, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Jo Ann S. Rinaudo, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–402–5658, rinaudoj@mail.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Tuberculosis Epidemiology. Date: May 15, 2007. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3258, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Michelle M. Timmerman, PhD, Scientific Review Administrator, Scientific Review Program, National Institutes of Health/NIAID, Room 3258, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, 301–451–4573, timmermanm@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Molecular and Cellular Basis of Thymus Function. Date: May 15, 2007. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3120, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Lynn Rust, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3120, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 402–3938, lr228v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 11, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1899 Filed 4–17–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 72, Number 74 (Wednesday, April 18, 2007)]
[Notices]
[Pages 19545-19546]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1894]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the

[[Page 19546]]

provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Initial Review Group; Diabetes, Endocrinology 
and Metabolic Diseases B Subcommittee.
    Date: May 30-31, 2007.
    Open: May 30, 2007, 3:30 p.m. to 4 p.m.
    Agenda: To review procedures and discuss policy.
    Place: Intercontinental Toronto Centre, 225 Front Street West, 
Toronto, ON.
    Closed: May 30, 2007, 4 p.m. to 7:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Intercontinental Toronto Centre, 225 Front Street West, 
Toronto, ON.
    Closed: May 31, 2007, 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Intercontinental Toronto Centre, 225 Front Street West, 
Toronto, ON.
    Contact Person: John F. Connaughton, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 916, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7797. connaughtonj@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Initial Review Group; Kidney, Urologic and 
Hematologic Diseases D Subcommittee.
    Date: June 27-28, 2007.
    Open: June 27, 2007, 2 p.m. to 2:30 p.m.
    Agenda: To review procedures and discuss policy.
    Place: Crystal City Courtyard by Marriott, 2899 Jefferson Davis 
Hwy, Arlington, VA 22202.
    Closed: June 27, 2007, 2:30 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crystal City Courtyard by Marriott, 2899 Jefferson Davis 
Hwy, Arlington, VA 22202.
    Closed: June 28, 2007, 8 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crystal City Courtyard by Marriott, 2899 Jefferson Davis 
Hwy, Arlington, VA 22202.
    Contact Person: Neal A. Musto, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 751, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7798, muston@extra.niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: April 11, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1894 Filed 4-17-07; 8:45am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.